STOCK TITAN

[Form 4] PAYCHEX INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Paychex (PAYX) — Form 4 insider activity: A company director reported equity awards dated 10/15/2025. The filing shows 725 shares of common stock acquired at $0, reflecting settlement of restricted stock units under the Amended and Restated 2002 Stock Incentive Plan. Following this, beneficial ownership stands at 67,364 shares, held directly.

The director also reported a new stock option grant for 3,061 shares at an exercise price of $127.52, granted on 10/15/2025, exercisable starting 10/15/2026 and expiring on 10/14/2035. The filing lists additional previously granted options with exercise prices and expirations on a rolling schedule.

Paychex (PAYX) — Attività insider Form 4: Un membro del consiglio di amministrazione ha riportato premi azionari datati 15/10/2025. La comunicazione mostra l'acquisto di 725 azioni ordinarie a 0 USD, riflettendo la liquidazione di unità azionarie vincolate ai sensi del Piano di Incentivi Azionari del 2002, come modificato e rivisto. Di conseguenza, la proprietà beneficiaria ammonta a 67.364 azioni, detenute direttamente.

Il direttore ha inoltre riportato una nuova assegnazione di opzioni azionarie per 3.061 azioni a un prezzo di esercizio di 127,52 USD, concessa il 15/10/2025, esercitabile dal 15/10/2026 e in scadenza il 14/10/2035. La dichiarazione elenca ulteriori opzioni già concesse in precedenza con prezzi di esercizio e scadenze secondo un calendario continuato.

Paychex (PAYX) — Actividad de insider Formulario 4: Un director de la empresa reportó premios en acciones fechados el 15/10/2025. La presentación muestra la adquisición de 725 acciones comunes a 0 USD, reflejando el asentamiento de unidades de acciones restringidas bajo el Plan de Incentivos Accionarios de 2002, modificado y reformulado. Tras ello, la propiedad beneficiosa asciende a 67.364 acciones, poseídas directamente.

El director también reportó una nueva concesión de opciones sobre acciones por 3.061 acciones a un precio de ejercicio de 127,52 USD, otorgada el 15/10/2025, ejercitable a partir del 15/10/2026 y con vencimiento el 14/10/2035. La declaración lista opciones previamente concedidas con precios de ejercicio y vencimientos según un calendario continuo.

Paychex (PAYX) — Form 4 내부자 활동: 이사 한 명이 2025년 10월 15일로 날짜가 기록된 주식 보상을 보고했습니다. 공시에는 0달러에 매수한 725주의 보통주가 표시되며, 2002년 주식 인센티브 계획(수정 및 재정의)에 따른 제한 주식 유닛의 정산을 반영합니다. 그 뒤로 실질적 소유권은 직접 보유하는 67,364주로 유지됩니다.

또한 이사는 3,061주에 대한 새로운 주식 매수 옵션 부여를 보고했으며 행사가격은 127.52달러이고 2025년 10월 15일에 부여되었으며, 2026년 10월 15일부터 행사 가능하고 2035년 10월 14일에 만료됩니다. 공시는 또한 이전에 부여된 옵션들을 행사가격과 만료일이 연속적인 일정으로 나열합니다.

Paychex (PAYX) — Activité d’initié Formulaire 4 : Un administrateur a déclaré des récompenses en actions datées du 15/10/2025. Le dossier indique l’acquisition de 725 actions ordinaires à 0 USD, reflétant le règlement des unités d’actions restreintes en vertu du Plan d’Incitations à Actions de 2002, tel que modifié et reformulé. Suite à cela, la propriété bénéficiaire s’élève à 67 364 actions, détenues directement.

L’administrateur a également signalé une nouvelle attribution d’options sur actions pour 3 061 actions à un prix d’exercice de 127,52 USD, accordée le 15/10/2025, exercice possible à partir du 15/10/2026 et arrivant à expiration le 14/10/2035. Le dossier répertorie d’autres options accordées précédemment avec des prix d’exercice et des dates d’expiration selon un calendrier continu.

Paychex (PAYX) — Form 4 Insider-Aktivität: Ein Vorstandsmitglied meldete Eigenkapitalzuteilungen datiert auf den 15.10.2025. Die Einreichung zeigt den Erwerb von 725 Stammaktien zum Preis von 0 USD, was die Abrechnung von Restricted Stock Units gemäß dem überarbeiteten 2002 Stock Incentive Plan widerspiegelt. Danach beträgt das begünstigte Eigentum 67.364 Aktien, direkt gehalten.

Der Direktor meldete außerdem eine neue Zuteilung von Aktienoptionen über 3.061 Aktien zu einem Ausübungspreis von 127,52 USD, am 15.10.2025 gewährt, ab dem 15.10.2026 ausübbar und mit Ablauf am 14.10.2035. Die Einreichung listet weitere zuvor gewährte Optionen mit Ausübungspreisen und Laufzeiten in einem fortlaufenden Zeitplan.

Paychex (PAYX) — نشاط المطلع Form 4: أبلغ عضو مجلس الإدارة عن منح أسهم بتاريخ 15/10/2025. يظهر الملف شراء 725 سهماً عاديًا بسعر تنفيذ 0 دولار، يعكس تسوية وحدات الأسهم المقيدة بموجب خطة الحوافز بالأسهم لعام 2002 كما جرى تعديلها وتحديثها. وبذلك تبلغ الملكية المستفيدة 67,364 سهماً، مملوكة بشكل مباشر.

كما أبلغ المدير عن منحة خيار أسهم جديدة لـ3,061 سهماً بسعر تنفيذ 127.52 دولاراً، مُنحت في 15/10/2025، قابلة للتنفيذ اعتباراً من 15/10/2026 وتنتهي في 14/10/2035. ويذكر الملف أيضاً خيارات أخرى مُمنوحة سابقاً مع أسعار تنفيذ وتواريخ انتهاء وفق جدول دوري مستمر.

Paychex (PAYX) — Form 4 内幕交易活动: 一位公司董事披露了日期为 2025-10-15 的股票奖励。文件显示以 0 美元购买了 725 股普通股,反映了在经修订的 2002 年股票激励计划下的受限股票单位结算。此后,实际拥有量为 67,364 股,直接持有。

该董事还报告了一项新的股票期权授予,为 3,061 股,行权价 127.52 美元,授予日为 2025-10-15,自 2026-10-15 起可行使,至 2035-10-14 失效。文件还列出以往授予的其他期权,其行权价格和到期日按滚动日程列示。

Positive
  • None.
Negative
  • None.

Insights

Routine Form 4: RSU settlement and new option grant.

The disclosure records two standard items: 725 shares acquired at $0 from RSU settlement and a fresh option grant for 3,061 shares at $127.52. RSUs convert into shares at no cash cost to the insider upon vesting, while options require payment of the exercise price to acquire shares.

The new option becomes exercisable on 10/15/2026 and expires on 10/14/2035, aligning with typical 10-year terms. The director’s direct holdings after the transactions are 67,364 shares. Actual share deliveries from options depend on future exercises.

Paychex (PAYX) — Attività insider Form 4: Un membro del consiglio di amministrazione ha riportato premi azionari datati 15/10/2025. La comunicazione mostra l'acquisto di 725 azioni ordinarie a 0 USD, riflettendo la liquidazione di unità azionarie vincolate ai sensi del Piano di Incentivi Azionari del 2002, come modificato e rivisto. Di conseguenza, la proprietà beneficiaria ammonta a 67.364 azioni, detenute direttamente.

Il direttore ha inoltre riportato una nuova assegnazione di opzioni azionarie per 3.061 azioni a un prezzo di esercizio di 127,52 USD, concessa il 15/10/2025, esercitabile dal 15/10/2026 e in scadenza il 14/10/2035. La dichiarazione elenca ulteriori opzioni già concesse in precedenza con prezzi di esercizio e scadenze secondo un calendario continuato.

Paychex (PAYX) — Actividad de insider Formulario 4: Un director de la empresa reportó premios en acciones fechados el 15/10/2025. La presentación muestra la adquisición de 725 acciones comunes a 0 USD, reflejando el asentamiento de unidades de acciones restringidas bajo el Plan de Incentivos Accionarios de 2002, modificado y reformulado. Tras ello, la propiedad beneficiosa asciende a 67.364 acciones, poseídas directamente.

El director también reportó una nueva concesión de opciones sobre acciones por 3.061 acciones a un precio de ejercicio de 127,52 USD, otorgada el 15/10/2025, ejercitable a partir del 15/10/2026 y con vencimiento el 14/10/2035. La declaración lista opciones previamente concedidas con precios de ejercicio y vencimientos según un calendario continuo.

Paychex (PAYX) — Form 4 내부자 활동: 이사 한 명이 2025년 10월 15일로 날짜가 기록된 주식 보상을 보고했습니다. 공시에는 0달러에 매수한 725주의 보통주가 표시되며, 2002년 주식 인센티브 계획(수정 및 재정의)에 따른 제한 주식 유닛의 정산을 반영합니다. 그 뒤로 실질적 소유권은 직접 보유하는 67,364주로 유지됩니다.

또한 이사는 3,061주에 대한 새로운 주식 매수 옵션 부여를 보고했으며 행사가격은 127.52달러이고 2025년 10월 15일에 부여되었으며, 2026년 10월 15일부터 행사 가능하고 2035년 10월 14일에 만료됩니다. 공시는 또한 이전에 부여된 옵션들을 행사가격과 만료일이 연속적인 일정으로 나열합니다.

Paychex (PAYX) — Activité d’initié Formulaire 4 : Un administrateur a déclaré des récompenses en actions datées du 15/10/2025. Le dossier indique l’acquisition de 725 actions ordinaires à 0 USD, reflétant le règlement des unités d’actions restreintes en vertu du Plan d’Incitations à Actions de 2002, tel que modifié et reformulé. Suite à cela, la propriété bénéficiaire s’élève à 67 364 actions, détenues directement.

L’administrateur a également signalé une nouvelle attribution d’options sur actions pour 3 061 actions à un prix d’exercice de 127,52 USD, accordée le 15/10/2025, exercice possible à partir du 15/10/2026 et arrivant à expiration le 14/10/2035. Le dossier répertorie d’autres options accordées précédemment avec des prix d’exercice et des dates d’expiration selon un calendrier continu.

Paychex (PAYX) — Form 4 Insider-Aktivität: Ein Vorstandsmitglied meldete Eigenkapitalzuteilungen datiert auf den 15.10.2025. Die Einreichung zeigt den Erwerb von 725 Stammaktien zum Preis von 0 USD, was die Abrechnung von Restricted Stock Units gemäß dem überarbeiteten 2002 Stock Incentive Plan widerspiegelt. Danach beträgt das begünstigte Eigentum 67.364 Aktien, direkt gehalten.

Der Direktor meldete außerdem eine neue Zuteilung von Aktienoptionen über 3.061 Aktien zu einem Ausübungspreis von 127,52 USD, am 15.10.2025 gewährt, ab dem 15.10.2026 ausübbar und mit Ablauf am 14.10.2035. Die Einreichung listet weitere zuvor gewährte Optionen mit Ausübungspreisen und Laufzeiten in einem fortlaufenden Zeitplan.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
TUCCI JOSEPH M

(Last) (First) (Middle)
911 PANORAMA TRAIL S.

(Street)
ROCHESTER NY 14625

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PAYCHEX INC [ PAYX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/15/2025 A 725(1) A $0 67,364 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $127.52 10/15/2025 A 3,061 10/15/2026 10/14/2035 Common Stock 3,061 $127.52 3,061 D
Stock Option $60.59 07/07/2017 07/06/2026 Common Stock 10,220 10,220 D
Stock Option $57.2 07/13/2018 07/12/2027 Common Stock 9,615 9,615 D
Stock Option $70.37 07/12/2019 07/11/2028 Common Stock 8,641 8,641 D
Stock Option $85.33 07/11/2020 07/10/2029 Common Stock 7,929 7,929 D
Stock Option $73.53 07/15/2021 07/14/2030 Common Stock 5,793 5,793 D
Stock Option $112.67 07/15/2022 07/14/2031 Common Stock 5,075 5,075 D
Stock Option $115 07/15/2023 07/14/2032 Common Stock 3,027 3,027 D
Stock Option $120.86 07/15/2024 07/14/2033 Common Stock 3,382 3,382 D
Common Stock $121.63 07/15/2025 07/14/2034 Common Stock 3,351 3,351 D
Stock Option $140.68 07/15/2026 07/14/2035 Common Stock 670 670 D
Explanation of Responses:
1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.
Prabha S. Bhandari, Attorney-in-fact 10/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Paychex (PAYX) disclose in this Form 4?

A director acquired 725 shares at $0 from RSU settlement and received a new stock option for 3,061 shares at $127.52, dated 10/15/2025.

How many shares does the insider own after the report for PAYX?

The filing shows 67,364 shares of common stock beneficially owned, held directly.

What are the terms of the new Paychex stock option grant?

The option covers 3,061 shares at an exercise price of $127.52, exercisable starting 10/15/2026 and expiring 10/14/2035.

What explains the $0 price on the 725 PAYX shares?

They reflect an RSU award settlement under the Amended and Restated 2002 Stock Incentive Plan, which converts to shares without a purchase price.

What is the insider’s relationship to Paychex?

The reporting person is a Director of Paychex, Inc.

Were any sales reported in this PAYX Form 4?

No sales are shown; the report lists an acquisition of 725 shares and a new option grant.
Paychex Inc

NASDAQ:PAYX

PAYX Rankings

PAYX Latest News

PAYX Latest SEC Filings

PAYX Stock Data

45.52B
321.69M
10.62%
81.49%
3.52%
Software - Application
Services-engineering, Accounting, Research, Management
Link
United States
ROCHESTER